USD 51.55
(9.31%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.47 Billion USD | 2.35% |
2022 | 2.41 Billion USD | 2.38% |
2021 | 2.36 Billion USD | 61.35% |
2020 | 1.46 Billion USD | 54.73% |
2019 | 946.3 Million USD | 37.38% |
2018 | 688.82 Million USD | 16035.44% |
2017 | 4.26 Million USD | -7.86% |
2016 | 4.63 Million USD | -4.51% |
2015 | 4.85 Million USD | 385.2% |
2014 | 1 Million USD | -26.47% |
2013 | 1.36 Million USD | -20.51% |
2012 | 1.71 Million USD | 71.1% |
2011 | 1 Million USD | 0.0% |
2010 | 1 Million USD | 0.0% |
2009 | 1 Million USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 2.22 Billion USD | -10.69% |
2024 Q3 | 2.48 Billion USD | 0.07% |
2024 Q2 | 2.31 Billion USD | 12.15% |
2023 Q2 | 2.48 Billion USD | -2.16% |
2023 FY | 2.47 Billion USD | 2.35% |
2023 Q4 | 2.47 Billion USD | -0.24% |
2023 Q3 | 2.48 Billion USD | 0.05% |
2023 Q1 | 2.53 Billion USD | 4.81% |
2022 Q3 | 2.41 Billion USD | -0.05% |
2022 Q1 | 2.36 Billion USD | -0.0% |
2022 Q4 | 2.41 Billion USD | -0.03% |
2022 FY | 2.41 Billion USD | 2.38% |
2022 Q2 | 2.42 Billion USD | 2.46% |
2021 Q2 | 2.05 Billion USD | 0.39% |
2021 Q4 | 2.36 Billion USD | 15.24% |
2021 FY | 2.36 Billion USD | 61.35% |
2021 Q3 | 2.05 Billion USD | -0.02% |
2021 Q1 | 2.04 Billion USD | 39.49% |
2020 FY | 1.46 Billion USD | 54.73% |
2020 Q1 | 1.63 Billion USD | 72.53% |
2020 Q2 | 1.68 Billion USD | 3.14% |
2020 Q3 | 1.7 Billion USD | 1.05% |
2020 Q4 | 1.46 Billion USD | -13.95% |
2019 Q3 | 500.78 Million USD | 1.37% |
2019 Q2 | 494.02 Million USD | -37.88% |
2019 FY | 946.3 Million USD | 37.38% |
2019 Q4 | 946.3 Million USD | 88.97% |
2019 Q1 | 795.29 Million USD | 15.46% |
2018 Q2 | 648.8 Million USD | 32.16% |
2018 Q3 | 673.42 Million USD | 3.79% |
2018 FY | 688.82 Million USD | 16035.44% |
2018 Q1 | 490.92 Million USD | 11399.77% |
2018 Q4 | 688.82 Million USD | 2.29% |
2017 Q3 | 4.51 Million USD | -0.9% |
2017 Q2 | 4.55 Million USD | -0.87% |
2017 Q1 | 4.59 Million USD | -0.88% |
2017 FY | 4.26 Million USD | -7.86% |
2017 Q4 | 4.26 Million USD | -5.36% |
2016 Q3 | 4.67 Million USD | -0.81% |
2016 Q1 | 4.75 Million USD | -2.1% |
2016 FY | 4.63 Million USD | -4.51% |
2016 Q4 | 4.63 Million USD | -0.86% |
2016 Q2 | 4.71 Million USD | -0.82% |
2015 Q3 | 3.53 Million USD | 1.35% |
2015 FY | 4.85 Million USD | 385.2% |
2015 Q4 | 4.85 Million USD | 37.26% |
2015 Q2 | 3.48 Million USD | 248.8% |
2015 Q1 | 1 Million USD | 0.0% |
2014 Q1 | 1.26 Million USD | -6.69% |
2014 FY | 1 Million USD | -26.47% |
2014 Q4 | 1 Million USD | 0.0% |
2014 Q3 | 1 Million USD | -15.04% |
2014 Q2 | 1.17 Million USD | -7.25% |
2013 Q1 | 1.62 Million USD | -5.03% |
2013 Q3 | 1.44 Million USD | -5.79% |
2013 Q4 | 1.36 Million USD | -6.14% |
2013 FY | 1.36 Million USD | -20.51% |
2013 Q2 | 1.53 Million USD | -5.35% |
2012 Q4 | 1.71 Million USD | -4.73% |
2012 FY | 1.71 Million USD | 71.1% |
2012 Q1 | 1 Million USD | 0.0% |
2012 Q2 | 1 Million USD | 0.0% |
2012 Q3 | 1.79 Million USD | 79.6% |
2011 Q2 | 1 Million USD | 0.0% |
2011 Q3 | 1 Million USD | 0.0% |
2011 Q4 | 1 Million USD | 0.0% |
2011 FY | 1 Million USD | 0.0% |
2011 Q1 | 1 Million USD | 0.0% |
2010 Q2 | 1 Million USD | 0.0% |
2010 Q4 | 1 Million USD | 0.0% |
2010 Q1 | 1 Million USD | 0.0% |
2010 FY | 1 Million USD | 0.0% |
2010 Q3 | 1 Million USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | 1 Million USD | 0.0% |
2009 FY | 1 Million USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2000 FY | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 3.07 Million USD | -80425.244% |
Biodesix, Inc. | 35.22 Million USD | -6927.242% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -221215.764% |
Castle Biosciences, Inc. | 14.19 Million USD | -17334.47% |
DarioHealth Corp. | 24.59 Million USD | -9966.065% |
IDEXX Laboratories, Inc. | 622.88 Million USD | -297.401% |
Illumina, Inc. | 1.48 Billion USD | -66.242% |
Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -3043707.486% |
iSpecimen Inc. | 29.13 Thousand USD | -8497483.248% |
Standard BioTools Inc. | 3.98 Million USD | -62047.778% |
23andMe Holding Co. | 67.84 Million USD | -3548.531% |
Medpace Holdings, Inc. | 142.12 Million USD | -1641.705% |
NeoGenomics, Inc. | 606.06 Million USD | -308.426% |
Inotiv, Inc. | 399.4 Million USD | -519.752% |
Psychemedics Corporation | 945 Thousand USD | -261841.376% |
Prenetics Global Limited | 867.21 Thousand USD | -285336.253% |
Precipio, Inc. | 106 Thousand USD | -2335132.075% |
RadNet, Inc. | 812.06 Million USD | -204.82% |
Sotera Health Company | 2.22 Billion USD | -11.318% |
Star Equity Holdings, Inc. | 1.14 Million USD | -216087.424% |
Exagen Inc. | 19.23 Million USD | -12771.645% |
Natera, Inc. | 282.94 Million USD | -774.851% |
Aspira Women's Health Inc. | 1.43 Million USD | -173001.119% |
Neogen Corporation | 888.39 Million USD | -178.632% |
Myriad Genetics, Inc. | 130.9 Million USD | -1791.021% |
ICON Public Limited Company | 3.66 Billion USD | 32.468% |
Bionano Genomics, Inc. | 7.17 Million USD | -34399.596% |
CareDx, Inc | 28.27 Million USD | -8653.611% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 79.17 Million USD | -3026.503% |
Guardant Health, Inc. | 1.13 Billion USD | -117.142% |
BioNexus Gene Lab Corp. | 98.76 Thousand USD | -2506249.544% |
Fulgent Genetics, Inc. | 10.11 Million USD | -24381.713% |
Sera Prognostics, Inc. | 840 Thousand USD | -294584.048% |
OPKO Health, Inc. | 222.03 Million USD | -1014.85% |
Personalis, Inc. | 1.23 Million USD | -200495.3% |
Applied DNA Sciences, Inc. | 739.16 Thousand USD | -334785.451% |
Star Equity Holdings, Inc. | 1.14 Million USD | -216087.424% |
MDxHealth SA | 35.56 Million USD | -6860.258% |
Prenetics Global Limited | 867.21 Thousand USD | -285336.253% |
ENDRA Life Sciences Inc. | 192.06 Thousand USD | -1288726.525% |
Mainz Biomed B.V. | 2.19 Million USD | -112626.372% |
Trinity Biotech plc | 54.65 Million USD | -4429.37% |
Neuronetics, Inc. | 59.28 Million USD | -4075.474% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -221215.764% |